You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 28 No. 3, March 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

{Delta}9-Tetrahydrocannabinol in Depressed Patients

Joel Kotin, MD; Robert M. Post, MD; Frederick K. Goodwin, MD

Arch Gen Psychiatry. 1973;28(3):345-348.


Abstract

{Delta}9-tetrahydrocannabinol (THC), given under double-blind conditions to eight hospitalized depressed patients for periods of up to seven days, failed to produce significant euphoria or an antidepressant response during the period of administration. Four patients who received the drug for seven days showed little change in mood but reported considerable drowsiness. In four patients, the drug trial was shortened because of adverse reactions; two of these patients experienced severe anxiety reactions with depersonalization after a single dose. Effects on cognitive functioning and vital signs were similar to those reported by other investigators in normal subjects. We should like to emphasize that our results were obtained with a small sample of hospitalized inpatients with moderate to severe depression. Different effects might be observed in other settings or in patients with less severe depressive symptoms.



Author Affiliations

Bethesda, Md

From the Section on Psychiatry, Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Md.


Footnotes

Accepted for publication Nov 15, 1972.

Reprint requests to Orange County Medical Center, 101 City Drive S, Orange, Calif 92668 (Dr. Kotin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Behavioral Treatment of Childhood Obsessive-Compulsive Disorder
Wolff and Rapoport
Behav Modif 1988;12:252-266.
ABSTRACT  

Biochemical Changes During Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder
Flament et al.
Arch Gen Psychiatry 1987;44:219-225.
ABSTRACT  

Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder: A Double-blind Controlled Study
Flament et al.
Arch Gen Psychiatry 1985;42:977-983.
ABSTRACT  

{beta}-Endorphin: Intravenous Infusion Causes Behavioral Change in Psychiatric Inpatients
Gerner et al.
Arch Gen Psychiatry 1980;37:642-647.
ABSTRACT  

Marijuana: Does It Have a Possible Therapeutic Use?
Cohen
JAMA 1978;240:1761-1763.
ABSTRACT  

Effects of Sleep Deprivation on Mood and Central Amine Metabolism in Depressed Patients
Post et al.
Arch Gen Psychiatry 1976;33:627-632.
ABSTRACT  

Marihuana and Social Behavior: A Controlled Study
Galanter et al.
Arch Gen Psychiatry 1974;30:518-521.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.